Den samlede mortalitetsincidens efter 30 dage var ligeledes signifikant reduceret fra 8, 9% for kontrolgruppen til 7, 8% i fondaparinuxgruppen (hazard rate 0, 87; 95% CI 0, 77- 0, 98; p = 0, 02).
The incidence of all cause mortality at Day 30 was also significantly reduced from 8.9% for the control group to 7.8% in the fondaparinux group (hazard ratio 0.87, 95% CI, 0.77; 0.98, p = 0.02).